Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...

"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

Scientists believe that Alzheimer's disease develops over decades, but it is usually not diagnosed until well after patients have started to experience serious symptoms of dementia. While researchers ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

A new study published in the journal of Neurology showed that reduced kidney function does not raise the incidence of ...

A recent study published in JAMA evaluates the potential of plasma biomarkers for Alzheimer’s disease (AD) and cardiometabolic risk factors to predict the risk of other types of dementia. Study: ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

The "Alzheimer Biomarker Based Diagnostic Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

PHILADELPHIA, Pennsylvania — Sleep-disordered breathing in healthy elderly subjects is associated with several biomarkers for Alzheimer's disease, leading researchers to think that sleep-disordered ...